Value investors are well aware that investing in technology companies is not an easy task. Additionally, valuing bio-tech companies is far more difficult. The Manual of Ideas conducted an interview with Humphrey Nokes of Cygna Negra, on this very topic. Nokes discusses how value investors can evaluate bio-tech companies in this video interview:


Sign Up For Our Free Newsletter and like our Facebook page for latest news updates and leaks. ValueWalk’s Under The Radar Hedge Fund Ideas Is Only $49.99 (CLICK HERE! IT'S LIMITED TIME OFFER)